|SEELOS THERAPEUTICS, INC. filed this Form S-3 on 02/01/2019|
Our audit committee currently consists of Richard W. Pascoe (Chair), Brian Lian, Ph.D. and Daniel J. O'Connor, J.D. All are non-
employee directors and are considered independent under the applicable independence standard promulgated by Nasdaq and the SEC. Our Board of Directors has currently designated Mr.
Pascoe as an "audit committee financial expert" as defined in Item 407(d)(5)(ii) of Regulation S-K. We believe that the audit committee members are capable of analyzing and evaluating our
financial statements and understanding internal controls over financial reporting.
© Apricus Biosciences, Inc.